Trial | NCT00645775  Report issue

Title

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome
The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    102
The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.
To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.

The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.

Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.
Study Started
Nov 30
2006
Primary Completion
Mar 31
2007
Study Completion
Apr 30
2007
Last Update
Mar 28
2008
Estimate

Dietary Supplement IGOB131

Comparison of 250 mg per day of Irvingia gabonensis to placebo

1 Placebo Comparator

Compare active to placebo

Criteria 

Inclusion Criteria:

BMI>26

Exclusion Criteria:

Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers
No Results Posted